Menora Mivtachim Holdings Ltd. Bluebird Bio, Inc. Transaction History

Menora Mivtachim Holdings Ltd.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 31, 2019	SELL	$59.47 - $93.1 $8.43 Million - $13.2 Million	-141,700 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$105.8 - $150.94 $5.26 Million - $7.5 Million	49,700 Added 54.02%	141,700 $24.2 Million
Q4 2017 Feb 13, 2018	BUY	$81.25 - $130.7 $7.48 Million - $12 Million	92,000	92,000 $16.4 Million

39.7M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $559M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Menora Mivtachim Holdings Ltd., based on Form 13F filings with the SEC.

Stay updated on Menora Mivtachim Holdings Ltd. with notifications on news.